Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Mutation Linked to Hereditary Kidney Disease

By Biotechdaily staff writers
Posted on 19 Dec 2002
A study has found that mutations in the uromodulin (UMOD) gene are linked to the development of two inherited kidney diseases, medullary cystic kidney disease 2 (MCKD2) and familial juvenile hyperuricemic nephropathy (FJHN). More...
The study was published in the December 2002 issue of the Journal of Medical Genetics.

The UMOD gene ordinarily produces the protein uromodulin (Tamm-Horsfall protein), which is the most abundant protein in normal urine and a major component of tubular and urinary casts.

Investigators from Wake Forest University Baptist Medical Center (Winston-Salem, NC, US) and the University of Pittsburgh (PA, US) used genetic linkage and haplotype analyses to study two large, multigenerational families with mutations at the chromosome 16p FJHN gene locus. To permit refinement of the candidate interval and localization of candidate genes, an integrated physical and genetic map of the candidate region was developed. DNA sequencing of candidate genes was performed to detect mutations in subjects affected with FJHN (three unrelated families) and MCKD2 (one family).

The data accumulated during the study provided the first direct evidence that MCKD2 and FJHN arise from mutation of the UMOD gene and are allelic disorders. The authors postulated that mutation of UMOD disrupted the tertiary structure of UMOD and was responsible for the clinical changes of interstitial renal disease, polyuria, and hyperuricemia found in MCKD2 and FJHN.

"There had previously been a report speculating that these two conditions were in fact variations of the same disease,” explained senior author Dr. Anthony J. Bleyer, associate professor of internal medicine (nephrology) at Wake Forest University. "Our research has been able to prove that they are.”
Wake Forest University Baptist Medical Center >> www.wfu.edu



Related Links:
Wake Forest University
University of Pittsburgh

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.